Skip navigation | ||
|
||
Medical Encyclopedia |
|
Other encyclopedia topics: | A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9 |
Contents of this page: | |
|
Definition Return to top
Skin lesions of coccidioidomycosis are skin symptoms of a fungal infection caused by Coccidioides immitis.
Causes Return to top
Coccidioidomycosis is a fungal infection most often found in the desert regions of the southwestern US, and in Central and South America. It is acquired by breathing in fungal particles from soil in these regions. The point of entry for this infection is the lung.
Up to one-half of affected individuals have mild or no symptoms. Immunosuppressed individuals, such as people with AIDS, cancer, or transplant recipients, are at higher risk of severe, widespread (disseminated) disease.
Skin lesions can occur in the early stages of coccidioidomycosis (during primary lung infection). They include erythema nodosum or erythema multiforme. These rashes usually clear without treatment and are believed to be caused by an immune response to the infection.
After primary infection in the lungs, the fungus itself may spread to other tissues including the skin, and lead to various skin lesions including papules, nodules, and ulcers. These lesions contain fungus within them and are a manifestation of disseminated (widespread) fungal disease.
Symptoms Return to top
Exams and Tests Return to top
The diagnosis depends on the stage of infection (primary versus disseminated). Diagnosis may include skin biopsy to find the fungus in a culture if disseminated disease is suspected.
Treatment Return to top
The mainstay of treatment includes antifungal medications. Depending on the form or stage of disease, intravenous or oral forms of medications may be used. Antifungal agents commonly used include amphotericin B, itraconazole, ketoconazole, or fluconazole. People with disseminated disease and underlying immunosuppression may require long-term treatment.
Outlook (Prognosis) Return to top
The outcome varies with the stage and extent of infection, as well as the underlying immune system status of the individual. Disseminated disease has the highest mortality rate, particularly in immunosuppressed individuals.
Possible Complications Return to top
When to Contact a Medical Professional Return to top
There are many types of skin lesions, and they can be hard to tell apart. Notify your medical provider if you develop skin lesions and suspect this condition, because you will need to be tested.
References Return to top
Chiller TM. Coccidioidomycosis. Infect Dis Clin North Am. 2003; 17(1): 41-57, viii.
Murray J, Nadel J. Textbook of Respiratory Medicine. 3rd ed. Philadelphia, Pa: WB Saunders; 2000.
Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. 5th ed. London, UK: Churchill Livingstone; 2000:2746-2755.
Galgiani JN, Ampel N, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis. 2005;41:1217-23.
Update Date: 9/5/2006 Updated by: D. Scott Smith, M.D., MSc, DTM&H, Chief of Infectious Disease & Geographic Medicine, Kaiser Redwood City, CA & Adjunct Assistant Professor, Stanford University. Review provided by VeriMed Healthcare Network.
Home | Health Topics | Drugs & Supplements | Encyclopedia | Dictionary | News | Directories | Other Resources | |
Copyright | Privacy | Accessibility | Quality Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 02 January 2008 |